A carregar...
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
The development of immune checkpoint inhibitors (ICIs) has been a major breakthrough in cancer immunotherapy. The increasing use of ICIs has led to the discovery of a broad spectrum of immune-related adverse events (irAEs). Immune-related myasthenia gravis (irMG) is a rare but life-threatening irAE....
Na minha lista:
| Publicado no: | Front Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7378376/ https://ncbi.nlm.nih.gov/pubmed/32765397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00634 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|